Matches in SemOpenAlex for { <https://semopenalex.org/work/W3180669524> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W3180669524 abstract "Adenoid cystic carcinoma (ACC) is a rare cancer of secretory glands, characterized by slow and unpredictable growth, unrelenting relapse and high rates of metastasis. Poor response to chemotherapy and targeted drugs has resulted in there being no approved therapies to date, which contributes to poor prognosis with less than a 20% 5-year survival rate in patients with high-risk ACC. A vast majority of ACC tumors are known to have recurrent chromosomal translocation t(6;9) or t(8;9) resulting in MYB/MYBL1-NFIB fusions, and high levels of MYB protein expression. Furthermore, a subset of ACC tumors expresses NOTCH1 activating mutations (20-25%) and hyperactive NOTCH signaling in both primary and recurrent/metastatic tumors. A previous report has demonstrated that an inhibitor of PRMT5 (protein arginine methyltransferase) shows favorable responsiveness in patients with advanced ACC in a phase I clinical trial. Here, we investigate mechanistic aspects as to how PRMT5 inhibition potentially regulates the unique molecular drivers of ACC tumor growth. Due to a limited number of validated in vitro cellular models, we selected a group of head and neck cancer cell lines, including those originating from salivary gland, along with MYB and NOTCH1-driven leukemia models, to evaluate the effects of PRMT5 inhibition on MYB and NOTCH regulated genes. Treatment with PRT543, a potent and selective PRMT5 inhibitor, decreased expression of MYB and its associated downstream gene GATA3, as well as ACC-related genes such as SOX4 and POU3F2. Furthermore, PRT543 downregulated MYB signaling (MYB, FOXM1, NIK and SKI) as well as MYB alternative isoforms MYB-9A and MYB-10A in MYB expressing leukemia cells. Intriguingly, treatment with PRT543 also downregulated the transcription factor, HSF4, that is uniquely linked to regulation by N-terminal truncated MYB, a variant driven by an alternative promoter (TSS2) and reported as being active in ACC tumors. In addition to regulation of MYB, we also show that PRT543 downregulates NOTCH1 expression as well as multiple NOTCH1 target genes in leukemia cells which harbor a NOTCH1 active mutation. Given these results, we investigated the ability of PRT543 to inhibit the growth of ACC PDX tumor models in vivo and demonstrate that PRT543 significantly inhibits the growth of ACC PDX tumors in vivo. We confirmed that PRT543 downregulates levels of global symmetric dimethylarginine (sDMA, a substrate of PRMT5) in the treated tumors. Further studies with PRT543 in ex vivo and in vivo ACC models are ongoing. Collectively, these findings provide a strong molecular rationale for exploring PRT543 as a potential therapeutic option for ACC tumors. PRT543 is currently under evaluation in a Phase I clinical trial in patients with advanced solid tumors and hematological malignancies (NCT03886831).Citation Format: Jack Carter, Koichi Ito, Venkat Thodima, Neha Bhagwat, Joseph Rager, Nicole Spardy Burr, Jeffrey Kaufman, Bruce Ruggeri, Peggy Scherle, Kris Vaddi. PRMT5 inhibition downregulates MYB and NOTCH1 signaling, key molecular drivers of adenoid cystic carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1138." @default.
- W3180669524 created "2021-07-19" @default.
- W3180669524 creator A5004443645 @default.
- W3180669524 creator A5004931244 @default.
- W3180669524 creator A5018193992 @default.
- W3180669524 creator A5038154559 @default.
- W3180669524 creator A5046355139 @default.
- W3180669524 creator A5060435781 @default.
- W3180669524 creator A5062031656 @default.
- W3180669524 creator A5062211526 @default.
- W3180669524 creator A5063295871 @default.
- W3180669524 creator A5078291899 @default.
- W3180669524 date "2021-07-01" @default.
- W3180669524 modified "2023-10-16" @default.
- W3180669524 title "Abstract 1138: PRMT5 inhibition downregulates MYB and NOTCH1 signaling, key molecular drivers of adenoid cystic carcinoma" @default.
- W3180669524 doi "https://doi.org/10.1158/1538-7445.am2021-1138" @default.
- W3180669524 hasPublicationYear "2021" @default.
- W3180669524 type Work @default.
- W3180669524 sameAs 3180669524 @default.
- W3180669524 citedByCount "2" @default.
- W3180669524 countsByYear W31806695242022 @default.
- W3180669524 countsByYear W31806695242023 @default.
- W3180669524 crossrefType "proceedings-article" @default.
- W3180669524 hasAuthorship W3180669524A5004443645 @default.
- W3180669524 hasAuthorship W3180669524A5004931244 @default.
- W3180669524 hasAuthorship W3180669524A5018193992 @default.
- W3180669524 hasAuthorship W3180669524A5038154559 @default.
- W3180669524 hasAuthorship W3180669524A5046355139 @default.
- W3180669524 hasAuthorship W3180669524A5060435781 @default.
- W3180669524 hasAuthorship W3180669524A5062031656 @default.
- W3180669524 hasAuthorship W3180669524A5062211526 @default.
- W3180669524 hasAuthorship W3180669524A5063295871 @default.
- W3180669524 hasAuthorship W3180669524A5078291899 @default.
- W3180669524 hasConcept C104317684 @default.
- W3180669524 hasConcept C111819275 @default.
- W3180669524 hasConcept C121608353 @default.
- W3180669524 hasConcept C126322002 @default.
- W3180669524 hasConcept C150194340 @default.
- W3180669524 hasConcept C161879069 @default.
- W3180669524 hasConcept C170240278 @default.
- W3180669524 hasConcept C2777546739 @default.
- W3180669524 hasConcept C2779231225 @default.
- W3180669524 hasConcept C2781187634 @default.
- W3180669524 hasConcept C29537977 @default.
- W3180669524 hasConcept C33288867 @default.
- W3180669524 hasConcept C502942594 @default.
- W3180669524 hasConcept C526805850 @default.
- W3180669524 hasConcept C54355233 @default.
- W3180669524 hasConcept C62478195 @default.
- W3180669524 hasConcept C62794011 @default.
- W3180669524 hasConcept C71924100 @default.
- W3180669524 hasConcept C86803240 @default.
- W3180669524 hasConcept C91965660 @default.
- W3180669524 hasConcept C95444343 @default.
- W3180669524 hasConceptScore W3180669524C104317684 @default.
- W3180669524 hasConceptScore W3180669524C111819275 @default.
- W3180669524 hasConceptScore W3180669524C121608353 @default.
- W3180669524 hasConceptScore W3180669524C126322002 @default.
- W3180669524 hasConceptScore W3180669524C150194340 @default.
- W3180669524 hasConceptScore W3180669524C161879069 @default.
- W3180669524 hasConceptScore W3180669524C170240278 @default.
- W3180669524 hasConceptScore W3180669524C2777546739 @default.
- W3180669524 hasConceptScore W3180669524C2779231225 @default.
- W3180669524 hasConceptScore W3180669524C2781187634 @default.
- W3180669524 hasConceptScore W3180669524C29537977 @default.
- W3180669524 hasConceptScore W3180669524C33288867 @default.
- W3180669524 hasConceptScore W3180669524C502942594 @default.
- W3180669524 hasConceptScore W3180669524C526805850 @default.
- W3180669524 hasConceptScore W3180669524C54355233 @default.
- W3180669524 hasConceptScore W3180669524C62478195 @default.
- W3180669524 hasConceptScore W3180669524C62794011 @default.
- W3180669524 hasConceptScore W3180669524C71924100 @default.
- W3180669524 hasConceptScore W3180669524C86803240 @default.
- W3180669524 hasConceptScore W3180669524C91965660 @default.
- W3180669524 hasConceptScore W3180669524C95444343 @default.
- W3180669524 hasLocation W31806695241 @default.
- W3180669524 hasOpenAccess W3180669524 @default.
- W3180669524 hasPrimaryLocation W31806695241 @default.
- W3180669524 hasRelatedWork W1986829345 @default.
- W3180669524 hasRelatedWork W2023472253 @default.
- W3180669524 hasRelatedWork W2403478927 @default.
- W3180669524 hasRelatedWork W2460430994 @default.
- W3180669524 hasRelatedWork W2772993264 @default.
- W3180669524 hasRelatedWork W2804564166 @default.
- W3180669524 hasRelatedWork W3045858142 @default.
- W3180669524 hasRelatedWork W3151930717 @default.
- W3180669524 hasRelatedWork W3180669524 @default.
- W3180669524 hasRelatedWork W4362541790 @default.
- W3180669524 isParatext "false" @default.
- W3180669524 isRetracted "false" @default.
- W3180669524 magId "3180669524" @default.
- W3180669524 workType "article" @default.